Abstract: Mapping the effective transverse relaxation time T 2 * represents an emerging MRI tool for noninvasive myocardial tissue characterization and holds the promise to provide means for assessing myocardial (patho)physiology in vivo. This work takes advantage of the linear increase of susceptibility effects with magnetic field strength which renders it appealing to perform T 2 * mapping at ultrahigh magnetic fields and enables temporally resolved T 2 * mapping. Recognizing this potential this study examines the applicability of myocardial CINE T 2 * mapping in healthy volunteers and hypertrophic cardiomyopathy (HCM) patients at 7.0 Tesla and investigates its capability to distinguish between healthy myocardium and myocardium affected by HCM.
Introduction
Myocardial tissue characterization with parametric MR (T 1 , T 2 and T 2 * ) is in the spotlight for the study of cardiac diseases such as hypertrophic cardiomyopathy (HCM) which is the most common genetic cardiac disease. T 2 * mapping is of particular relevance since it is a surrogate of a number of physiological parameters including blood oxygenation, blood volume fraction, hematocrit and myocardial wall stress. T 2 * mapping at ultrahigh magnetic field strengths (B 0 ≥ 7.0 T) permits the temporal assessment of myocardial T 2 * changes across the cardiac cycle [1, 2] which allows probing of different (patho)physiological states of the myocardium and holds the promise to facilitate distinction of healthy and pathologic tissue. Additionally, the increase of susceptibility effects at higher magnetic fields may be useful to lower the detection level and to extend the dynamic range of the sensitivity for monitoring T 2 * changes [3] which renders it conceptually appealing to perform T 2 * mapping at ultrahigh fields. Myocardial BOLD contrast or T 2 * are commonly regarded as surrogates for myocardial tissue oxygenation [4] , but the factors influencing T 2 * are manifold [5] . 
Material and methods
For this proof-of-principle study six healthy volunteers (4 male, age=50.0±12.4, BMI=23.9±2.9 kg/m 2 ) and six age and body mass index matched patients with confirmed HCM (4 male, age=52.7±17.5, BMI=25.2±1.9 kg/m 2 )
were examined using a 7.0 T whole body MR system (Siemens, Erlangen, Germany) equipped with a 16 channel RF-transceiver array enabling cardiac MRI at 7.0 Tesla [7] . High spatial resolution CINE T 
Results
All volunteers and patients involved in the clinical proof-ofprincipal study tolerated the breath-hold 2D CINE T 2 * mapping acquisitions (mean examination time: 13±1 minutes in healthy volunteers and 12±1 minutes in patients). Myocardial T 2 * was found to change periodically across the cardiac cycle in healthy controls and HCM patients. A systolic increase and diastolic decrease of T 2 * were observed in both groups. The diastolic T 2 * decrease was less steep in patients. The periodic T 2 * variation was paralleled by changes in septal wall thickness (SWT) and inner LV radius. Figure 3 shows average time courses of septal T 2 * , wall thickness and inner LV radius across the cardiac cycle for healthy controls and patients. Both, SWT and T 2 * were significantly higher in patients compared to healthy controls. Mean SWT averaged for all cardiac phases was found to be 7.3±1.2mm in healthy controls compared to 14.1±2.5mm in patients. Mean septal 
Discussion and conclusion
This study investigated the relation of myocardial T 2 * and morphology and sought to validate the hypothesis, that myocardial T 2 * and its time course across the cardiac cycle might be altered in HCM patients compared to healthy controls. The main finding of this study is that ventricular septal T 2 * changes periodically across the cardiac cycle in healthy controls and patients suffering from HCM and that it is significantly increased in HCM patients. While temporal variations of myocardial T 2 * have been attributed previously to changing myocardial blood volume fraction related to left ventricular blood pressure and resulting wall stress rather than changes in tissue oxygenation [2] , two main factors are assumed to cause the observed overall T 2 * increase in HCM. Improved tissue oxygenation in the presence HCM is very unlikely and was hence excluded as a potential cause for the observed T 2 * increase. Instead, first, T 2 has been reported to be elevated in HCM [12, 13] related to inflammation and resulting edema associated with the formation of fibrosis. A T 2 increase would also increase T 2 * and is supported by hyperintense areas in
LGE images associated with fibrosis coinciding with areas of increased T 2 * . Second, reduced myocardial perfusion and ischemia are common in HCM [14] . This condition reduces tissue blood volume fraction thereby decreasing the impact of deoxygenated hemoglobin on T 2 * and could hence explain the T 2 * increase. Presence of LGE and perfusion deficits were associated with a higher risk for a poor outcome in HCM patients [15, 16] . Hence our results suggest that myocardial T 2 * mapping might support risk stratification in HCM. The coincidence of regions showing reduced T 2 * changes across the cardiac cycle as Figure 3 : Course of mean septal wall thickness, inner LV radius and mean septal T2 * plotted over the cardiac cycle averaged for all healthy controls (left) and all patients (right). Relative cardiac phase 0 indicates the beginning of the cardiac cycle. T2 * changes periodically over the cardiac cycle increasing in systole and decreasing in diastole in both, healthy controls and HCM patients, but is significantly higher in HCM patients. 
